163 results
8-K
EX-99.1
FGEN
FibroGen Inc
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
Healthcare Security Administration (NHSA). Roxadustat is included on the NRDL for the treatment of anemia in chronic kidney disease (CKD), covering patients … activities including marketing, market access, key accounts and sales.
About Anemia Associated with Chronic Kidney Disease in China
Anemia commonly
8-K
EX-99.1
FGEN
FibroGen Inc
20 Aug 21
Other Events
12:00am
of Chronic Kidney Disease
Roxadustat is the first orally administered hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor available … for adult patients with anemia associated with chronic kidney disease in Europe
TOKYO, August 19, 2021 – Astellas Pharma Inc. (TSE: 4503, President and CEO
8-K
EX-99.1
FGEN
FibroGen Inc
24 Jul 19
Other Events
9:46pm
Exhibit 99.1
The New England Journal of Medicine (NEJM) publishes roxadustat CHINA PHASE 3 RESULTS for the TREATMENT OF anemia IN CHRONIC KIDNEY … of Medicine (NEJM)1 from the China Phase 3 trial of the efficacy and safety of roxadustat treatment for anemia in chronic kidney disease patients
8-K
EX-99.2
FGEN
FibroGen Inc
24 Jul 19
Other Events
9:46pm
Exhibit 99.2
Roxadustat CHINA PHASE 3 TRIAL FOR TREATMENT OF ANEMIA
in CHRONIC KIDNEY DISEASE PATIENTS NOT On DIALYSIS
Published In THE new … of roxadustat treatment compared to placebo for anemia in non-dialysis patients (NDD) with chronic kidney disease (CKD) in the People’s Republic
8-K
EX-99.1
FGEN
FibroGen Inc
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
Exhibit 99.1
Press Release
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic … with chronic kidney disease (CKD).1 CKD impacts one in 10 people globally, of whom one in five are affected by anemia.2, 3 Anemia of CKD is associated
8-K
EX-99.1
6h1uomow
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
77zjv xrk
20 Sep 18
Other Events
8:30am
8-K
EX-99.1
5y01y0k7t3bczpx 3n
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
ks3woff6pr4evmljnmx
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
ec3znt2
31 May 18
Astellas and FibroGen Announce Topline Results
8:00am
8-K
EX-99.1
io9pz
26 Oct 18
Other Events
12:00am
8-K
hof9 3difvnabn44
24 Jul 19
Other Events
9:46pm
8-K
EX-99.1
vfi5y1yuxpop
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
izdbfzc
18 Dec 18
FibroGen Announces Approval of Roxadustat in China for the Treatment of
12:00am
8-K
EX-99.1
o7mm0k
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
hx37t7zz8 3fj6
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
EX-99.1
sabl2l38rtv
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
wkmc4cywvd2axjwrg
1 Oct 18
Other Events
12:00am
8-K
EX-99.1
ogl7 4731qxc52r
7 Jun 18
Other Events
7:31am
8-K
EX-99.1
hlv2mtdrbsj4fop
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm